首页> 外文期刊>Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association >Reduction of hospital stay and cost after the implementation of a clinical pathway for radical gastrectomy for gastric cancer.
【24h】

Reduction of hospital stay and cost after the implementation of a clinical pathway for radical gastrectomy for gastric cancer.

机译:实施胃癌根治性胃切除术的临床途径后,减少住院时间和费用。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Clinical pathways have been used for various surgical procedures to improve outcomes and reduce costs. Radical gastrectomy is a major surgery for the treatment of gastric cancer. This study serves to evaluate the difference in clinical outcomes before and after patients were managed on a multidisciplinary gastrectomy pathway. METHODS: Between 2000 and 2005, 115 consecutive patients who underwent gastrectomy were categorized into a pre-pathway group and a pathway group. This corresponded to the implementation of the clinical pathway in August 2002. The 61 patients in the pathway group were managed according to a multidisciplinary program, while the 54 patients in the pre-pathway group were managed conventionally. The clinical outcomes and hospital costs were then assessed and compared. RESULTS: The two groups were similar in terms of demographics, comorbidities, types of gastrectomies, and pathological cancer staging. The postoperative length of hospital stay (LOS) was 9 days for the pathwaygroup and 11 days for the pre-pathway group (P=0.02), and the total LOS in the two groups was 11 and 14 days, respectively (P=0.02). The cost of hospitalization for the pathway patients was SDollars 13 338, which was significantly lower compared to the SDollars 17 371 cost for the pre-pathway patients (P=0.047). CONCLUSION: Clinical pathways may reduce hospital stay and costs for patients undergoing gastrectomy for the treatment of gastric cancer.
机译:背景:临床途径已用于各种外科手术,以改善疗效并降低成本。根治性胃切除术是治疗胃癌的主要手术。这项研究旨在评估在多学科胃切除术路径上管理患者之前和之后临床结果的差异。方法:在2000年至2005年之间,将115例行胃切除术的连续患者分为预通路组和通路组。这与2002年8月实施临床路径相对应。路径组中的61例患者按照多学科计划进行治疗,而路径前组中的54例患者则按常规进行治疗。然后评估并比较临床结局和医院费用。结果:两组在人口统计学,合并症,胃直肠切除术类型和病理癌症分期方面相似。通路组的术后住院时间(LOS)为9天,通路前组为11天(P = 0.02),两组的总LOS分别为11天和14天(P = 0.02)。 。通路患者的住院费用为SDollars 13 338,比通路前患者的SDollars 17 371的费用低得多(P = 0.047)。结论:临床途径可减少接受胃切除术治疗胃癌患者的住院时间和费用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号